TuHURA Biosciences, Inc. (HURA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-100.8%

-$0.01

vs $1.72 price

Levered DCF

$0.06

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-5.35

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-1.2×	-3.38×	-0.49×	-0.02×	-0.03×	-0.04×	-0.02×	-0.01×
P/B	1.73×	5.23×	-2.69×	0.03×	-0.95×	0.16×	0.78×	0.05×
P/S	0×	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-1.14×	-3.67×	-0.35×	0.97×	0.19×	0.23×	0.24×	0.45×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	0.78×	3.68×	1.16×	5.13×	0.79×	4.24×	1.03×	1.94×
Debt / equity	0.03×	0.01×	-1.5×	0.01×	-0.86×	0×	0×	0×
Interest coverage	-50.85×	-4.26×	-452.22×	0×	-36.04×	-179.77×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	1.1%	0.5%	3.9%	8.9%
Payout ratio	-0.0%	0.0%	0.0%	0.0%	-0.0%	-0.0%	-0.1%	-0.1%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-143.6%	-148.6%	533.8%	-119.1%	3030.3%	-362.0%	-3470.0%	-409.1%
Return on invested capital	-145.7%	-119.3%	-1074.9%	-118.9%	21862.0%	-200.4%	-3096.6%	-426.9%
Return on assets	-109.9%	-108.6%	-190.7%	-96.4%	-354.0%	-282.8%	-310.6%	-199.3%
Free cash flow yield	-76.4%	-19.4%	-286.9%	-2365.8%	-925.3%	-1123.9%	-3861.7%	-6721.0%
Earnings yield	-82.9%	-28.4%	-198.4%	-4593.6%	-3193.3%	-2281.3%	-4445.2%	-8548.8%
Enterprise value	$33.3M	$63.9M	$2.9M	-$13.8M	-$4.2M	-$8.9M	-$2.2M	-$3.6M
Net debt / EBITDA	0.1×	0.71×	0.16×	0.99×	0.23×	0.28×	0.26×	0.46×
Cash conversion cycle (days)	0	0	-12,389	-11,654	-2,517	-25,310	-73,402	-38,950